Jazz Pharmaceuticals (JAZZ) PT Raised to $175 at Deutsche Bank
Tweet
Share
E-mail
Get Alerts JAZZ Hot Sheet
Price: $227.99 +0.92%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 23
Join SI Premium – FREE
Deutsche Bank raised its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $175.00 (from $174.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- Allegiant Travel Company (ALGT) PT Raised to $103 at UBS
- Constellation Brands (STZ) PT Lowered to $157 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
